Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $89.19M.
ENTERPRISE VALUE (EV)
$89.19M
Fulcrum Therapeutics, Inc.
Market Cap
$282.68M
Enterprise Value (EV)
$89.19M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | $282.68M | $89.19M |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | $277.82M |
| Aurora Cannabis Inc. (ACB)vs › | $279.29M | $211.88M |
| SAB Biotherapeutics, Inc. (SABS)vs › | $277.96M | $274.83M |
| Abeona Therapeutics Inc. (ABEO)vs › | $287.54M | $251.18M |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.15M | $124.19M |
| Standard BioTools Inc. (LAB)vs › | $288.27M | $46.33M |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $288.49M | $236.94M |
| Fate Therapeutics, Inc. (FATE)vs › | $275.66M | $318.91M |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $274.22M | $74.51M |
Market Cap
$282.68M
Total Debt
$4.04M
Cash
$197.53M
Enterprise Value
$89.19M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
